Bipolar Disorder Clinical Trial
Official title:
Evaluation of Generalization Paradigm Patterns Among Different Psychiatric Disorders (Schizophrenia, Affective Spectrum and Anxiety Disorders) - an Open, Single Center, Longitudinal Study
Learning includes the ability to generalize to new situations and respond to similar, yet
not identical stimuli. In previous work, focused on stimulus generalization in healthy
volunteers, tones that were negatively reinforced induce wider generalization curves than
tones that were positively reinforced, and these in turn induce wider curves than neutral
memory (Schechtman et al, 2010).
The current study aimed to evaluate those patterns in different clinical disorders
(including Schizophrenia, Bipolar disorder, MDD, Anxiety disorders (Panic and GAD) and PTSD,
and healthy subjects that would be used as a control), with consideration whether those
patterns are unique to any specific disorder or state.
The generalization patterns evaluation would conduct twice though enable to compare the
stability of those patterns during the course of the illness (i.e during remission compared
to acute state).
The basic paradigm based on conditioning of a tone (sound) with unpleasant noise, and
extinction of that conditioning afterword. During the 60 minutes of evaluation, the
capability to discriminate between the original tone and similar but not identical tones,
and the tendency to categorize similar tones as identical to the original tone. A neutral
tone without conditioning will be used as reference. The clinical diagnosis will conduct by
a senior psychiatrist, and the state would be evaluated using standard questionnaires
Status | Recruiting |
Enrollment | 180 |
Est. completion date | June 2013 |
Est. primary completion date | December 2012 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 20 Years to 65 Years |
Eligibility |
Inclusion Criteria: - Men and women 20-65 years of age. - Primary DSM-IV diagnosis of Schizophrenia, Schizoaffective, Bipolar (1 or 2) , Major depressive Disorder , Generalized anxiety disorder, panic disorder, post traumatic stress disorder based on SCID and confirmed by a senior psychiatrist, Or subjects without axis I or II diagnosis (control group). - Capable and willing to provide informed consent. In any case when there is doubt about the patients' capacity to sign an informed consent, an independent doctor will assess the patient capacities to make treatment decisions with the clinical tool MacCAT-T. - Able to adhere to the evaluation schedule. - Able to read, hear, write and speak Hebrew. - Has signed a written informed consent to participate in the study. Exclusion Criteria: - Patients with acute, unstable, significant, or untreated medical illness besides schizophrenia, anxiety disorder or affective disorder, including alcohol and drug dependence. - Subjects with significant cognitive impairment including dementia, history of head injury, mental retardation, or any other cause to "organic" cognitive impairment. - Current suicidal ideation or history of a suicide attempt in the past six month - Subjects who were under compulsory hospitalization. - Subjects with any other dominant axis I or II diagnosis mainly anxiety disorders, which might interfere with the evaluation of the above disorders. |
Observational Model: Case Control, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
Israel | Shalvat Mental Health Center | Hod hasharon |
Lead Sponsor | Collaborator |
---|---|
Shalvata Mental Health Center | Weizmann Institute of Science |
Israel,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Generalization pattern differentiation | Compare the generalization curve and the differentiation between positive, negative and neutral valency bias | 60 minutes | No |
Secondary | State or trait differentiation | to find the stability of the outcome between the two visits, and whether there is correlation with clinical state and the generalization patterns | 4-24 weeks | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT02855762 -
Targeting the Microbiome to Improve Clinical Outcomes in Bipolar Disorder
|
N/A | |
Recruiting |
NCT05915013 -
Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response
|
Phase 1 | |
Recruiting |
NCT05206747 -
Ottawa Sunglasses at Night for Mania Study
|
N/A | |
Completed |
NCT02513654 -
Pharmacokinetics, Safety and Tolerability of Repeat Dosing Lamotrigine in Healthy Chinese Subjects
|
Phase 1 | |
Recruiting |
NCT06313918 -
Exercise Therapy in Mental Disorders-study
|
N/A | |
Completed |
NCT02304432 -
Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine
|
Early Phase 1 | |
Recruiting |
NCT06197048 -
Effect of Nutritional Counseling on Anthropometry and Biomarkers in Patients Diagnosed With Schizophrenia/Psychosis or Bipolar Affective Disorder
|
N/A | |
Completed |
NCT03497663 -
VIA Family - Family Based Early Intervention Versus Treatment as Usual
|
N/A | |
Completed |
NCT04284813 -
Families With Substance Use and Psychosis: A Pilot Study
|
N/A | |
Completed |
NCT02212041 -
Electronic Cigarettes in Smokers With Mental Illness
|
N/A | |
Recruiting |
NCT05030272 -
Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health Settings
|
N/A | |
Recruiting |
NCT04298450 -
ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention
|
N/A | |
Active, not recruiting |
NCT03641300 -
Efficacy of Convulsive Therapies for Bipolar Depression
|
N/A | |
Not yet recruiting |
NCT04432116 -
Time and Virtual Reality in Schizophrenia and Bipolar Disorder
|
N/A | |
Completed |
NCT02970721 -
Use of Psychotropic Medications Among Pregnant Women With Bipolar Disorder
|
||
Terminated |
NCT02909504 -
Gao NARASD Lithium Study
|
Phase 4 | |
Terminated |
NCT02893371 -
Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
|
||
Recruiting |
NCT02481245 -
BezafibrateTreatment for Bipolar Depression: A Proof of Concept Study
|
Phase 2 | |
Recruiting |
NCT03088657 -
Design and Methods of the Mood Disorder Cohort Research Consortium (MDCRC) Study
|